SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?


To: Phil Cressman who wrote (903)5/8/1998 8:11:00 PM
From: DMB1 Recommendation  Read Replies (1) | Respond to of 2135
 
re: "For example Ligand (LGND) has a drug ready for NDA to treat Karposi's which is in a gel or capsul form. It works extremely well and is ready to market, it is in advanced trials on other cancers."

Be aware that Kaposi's sarcoma is becoming a rare disease. While the HIV epidemic continues, there are far fewer new cases of KS perhaps due to changes in behavior among gay men affecting the transmission of the Kaposis Sarcoma virus.